Results 211 to 220 of about 29,800 (242)
Some of the next articles are maybe not open access.

Incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) in France during 2003–16: a four‐source capture–recapture estimate

British Journal of Dermatology, 2020
Because of its rarity, the exact incidence of and mortality from epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) is difficult to establish and closely depends on the size and type of the data source.
G. Chaby   +11 more
semanticscholar   +1 more source

Retrospective review of drug‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis cases at a pediatric tertiary care institution

Pediatric dermatology, 2020
Stevens‐Johnson syndrome and toxic epidermal necrolysis represent important sources of potential mortality and morbidity in children. There is a need for more clinical data in this population to determine whether specific treatments preferentially ...
C. Sibbald   +4 more
semanticscholar   +1 more source

Antiepileptic combination therapy with Stevens‐Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database

Epilepsia, 2020
Stevens‐Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are immune‐mediated diseases characterized by an extensive loss of the epidermal skin layer, often resulting in death.
Y. Noguchi   +4 more
semanticscholar   +1 more source

TOXIC EPIDERMAL NECROLYSIS

Dermatologic Clinics, 2000
Toxic epidermal necrolysis (TEN) is a rare but life-threatening adverse drug reaction. Implicated drugs are sulfonamides, anticonvulsants, allopurinol, and pyrazolone derivatives. Recently, advances in pathogenesis have been made in two directions. It is now known that (1) most patients with TEN have an abnormal metabolism to the culprit drug; and (2 ...
Jean Revuz, Pierre Wolkenstein
openaire   +3 more sources

Chronic pain: a long‐term sequela of epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) – prevalence, clinical characteristics and risk factors

Journal of the European Academy of Dermatology and Venereology, 2020
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are associated with various sequelae. Chronic pain, one of these sequelae, has never been systematically evaluated.
J. Lefaucheur   +9 more
semanticscholar   +1 more source

Hyperamylasemia in Toxic Epidermal Necrolysis

Archives of Dermatology, 1993
To the Editor.— Mucous membranes and systemic manifestations of toxic epidermal necrolysis (TEN) (also known as Lyell's syndrome) include oropharyngeal, ocular, genital, pulmonary, and intestinal involvement. 1,2 Hyperamylasemia was reported in only a few cases and its origin, ie, salivary and/or pancreatic, remained controversial.
Michel Devanlay   +5 more
openaire   +3 more sources

Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis

Acta bio-medica : Atenei Parmensis, 2019
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be considered a late-onset allergic reaction, can cause serious long-term sequelae. SJS/TEN are considered a spectrum of life-threatening adverse drug reactions. They have the
Liotti Lucia   +9 more
semanticscholar   +1 more source

TOXIC EPIDERMAL NECROLYSIS

International Journal of Dermatology, 1992
Toxic epidermal necrolysis is a severe mucocutaneous reaction pattern characterized by fever, systemic toxicity, tenderness, erythema, and widespread exfoliation. Lyell1 of Glasgow, Scotland, and Lang and Walker2 of Cape Town, South Africa, independently described this syndrome in 1956.
openaire   +3 more sources

Plasmapheresis in toxic epidermal necrolysis

International Journal of Dermatology, 1997
Abstract Background The treatment of toxic epidermal necrolysis (TEN) is usually based on the removal of the offending drug(s), fluid replacement, nutritional support, and local management. The mortality and morbidity, however, remain high and the death rate may be reduced to 10% only in special centers that use biologic dressings. Plasma exchange (PE)
F. Chrysomallis   +5 more
openaire   +2 more sources

Toxic epidermal necrolysis

BMJ, 2008
Surely there aren9t emergencies in dermatology?
A. Devkaran, Shikha Gupta
openaire   +2 more sources

Home - About - Disclaimer - Privacy